Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma

PURPOSE: In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [(18)F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. METHODS: Twenty-five patients with s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Nucl Med Mol Imaging
Asıl Yazarlar: Sachpekidis, Christos, Kopp-Schneider, Annette, Pan, Leyun, Papamichail, Dimitrios, Haberkorn, Uwe, Hassel, Jessica C., Dimitrakopoulou-Strauss, Antonia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8113306/
https://ncbi.nlm.nih.gov/pubmed/33336264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05137-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller